Affirmed and Memorandum Opinion filed March 24, 2022.
In The
Fourteenth Court of Appeals
NO. 14-20-00704-CV
JEFFREY LANE POWE, Appellant
V.
DOWDUPONT INC. D/B/A THE DOW CHEMICAL COMPANY, Appellee
On Appeal from the 412th District Court
Brazoria County, Texas
Trial Court Cause No. 101748-CV
MEMORANDUM OPINION
In this personal-injury case, the trial court granted the defendant’s summary-
judgment motion on the ground of limitations. On appeal, the plaintiff argues that
the judgment must be reversed because his cause of action did not accrue until he
was diagnosed with cancer. We affirm.
I.
Welder Jeffrey Powe was exposed to radiation in May 2014 while working on
premises owned by the Dow Chemical Company. He was diagnosed with cancer in
July 2017, and in March 2019, he sued Dow under theories of negligence, negligence
per se, and premises liability. Before Dow answered, Powe filed an amended
petition, but he did not assert the discovery rule in either pleading. Dow raised the
affirmative defense of limitations in its answer. Powe filed a second amended
petition, and again did not raise the discovery rule. Dow answered the second
amended petition and again asserted that the claims were barred by limitations.
Sixteen months after suit was filed, Dow moved for summary judgment on
the ground that Powe’s personal-injury claims are barred by the two-year statute of
limitations. See TEX. CIV. PRAC. & REM. CODE ANN. § 16.003(a). Dow pointed out
in the motion that Powe had not pleaded the discovery rule. Powe responded that the
discovery rule delayed the accrual of his causes of action until his cancer diagnosis
in 2017, which was less than two years before he filed suit. Two days after filing his
summary-judgment response, Powe filed a third amended petition pleading the
discovery rule. Dow moved to strike the third amended petition, and at the same
time, Dow filed a summary-judgment reply in which Dow argued that Powe could
not avail himself of the discovery rule because he had not timely pleaded it. The trial
court granted both Dow’s motion to strike the amended pleading and its motion for
summary judgment.
II.
Powe raises a global point of error that summary judgment was improper. He
argues that his cause of action did not accrue until he was diagnosed with cancer.
2
Powe suffered a legal injury when he was exposed to radiation on May 16,
2014, and sought treatment from an emergency room for flu-like symptoms several
days later. But Powe filed suit nearly five years after his radiation exposure, and
“[a]bsent some exception, such as the discovery rule, injuries that arise or develop
after the legal injury are still deemed to have accrued on the same date as the legal
injury that caused them.” Schlumberger Tech. Corp. v. Pasko, 544 S.W.3d 830, 834
(Tex. 2018) (per curiam). Moreover, a defendant moving for summary judgment on
the affirmative defense of limitations has no burden to negate the discovery rule
unless it has been pleaded or otherwise raised. KPMG Peat Marwick v. Harrison
Cnty. Hous. Fin. Corp., 988 S.W.2d 746, 748 (Tex. 1999).
On appeal, Powe argues that the discovery rule applies, deferring the accrual
of his cause of action until he was diagnosed with cancer in July 2017. Although
Powe raised the discovery rule in his summary-judgment response, the trial court
sustained Dow’s objection that Powe had failed to plead it. Powe does not challenge
the trial court’s ruling sustaining this objection or the ruling striking his third
amended petition, in which he first attempted to plead the discovery rule. Powe also
does not contend that he raised the discovery rule in his live pleading, that is, his
second amended petition. Because Powe failed to challenge the trial court’s ruling
that prevents us from considering the discovery rule, we cannot consider it as a
ground for reversal.
Powe also argues cancer is a latent disease that tolls the limitations. However,
medical records show that he went to the emergency room shortly after the incident
and visited an oncologist in July of 2014 because he was worried about radiation
poisoning. On this record, Powe has not established a latent disease under the limited
rule as set out by the Supreme Court. See Schlumberger at 834–35.
3
III.
Among the evidence offered in support of its limitations defense, Dow
included medical records recounting that Powe was exposed to radiation poisoning,
and “[a]t that time” he was hospitalized for nine days for “what was subsequently
diagnosed as acute radiation poisoning.” On appeal, Powe reurges his trial-court
objections that the exhibit references hearsay and that its references to earlier
medical records violate the best-evidence rule.
To preserve objections to such defects of form, the complaining party must
obtain a ruling on the objection. See UT Health Sci. Ctr.-Houston v. Carver, No. 01-
16-01010-CV, 2018 WL 1473897, at *5 (Tex. App.—Houston [1st Dist.] Mar. 27,
2018, no pet.) (mem. op.). Because Powe failed to obtain rulings, these objections
have not been preserved for review. See TEX. R. APP. P. 33.1(a).
IV.
Because Powe’s appellate arguments do not present grounds for reversal, we
affirm the trial court’s judgment.
/s/ Tracy Christopher
Chief Justice
Panel consists of Chief Justice Christopher and Justices Zimmerer and Wilson.
4